Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03724903Completed
Randomised, open-label trial of triamcinolone acetonide in idiopathic granulomatous mastitis (IGM), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Complete Clinical Response at 1 year. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03724903.